Market

Moschip to acquire 73% stake in Belagavi-based Vyvya Labs for Rs 245.49 croreAll about Belgaum The stock jumped 7% after the company acquired a 73% stake in Viavya Labs to boost semiconductor capabilities.business mind Moschip Technologies board approves acquisition of 73% stake in Vyavya Labsbusiness standard Multibagger semiconductor company approves acquisition worth Rs 245 crore;…

PPF investment: How ₹5K monthly grows to ₹41 lakh and why it matters before the 5thpeppermint PPF Income Strategy: How to get ₹61,000 monthly pension from your Public Provident Fund investment? view calculationmsn How to build a corpus of ₹1.03 crore and earn ₹61,000/month through PPF in 25 years? | The lock-in period for PPF…

US Section 301 probe: India rejects allegations, requests termination of both probesmoneycontrol.com ‘Concerns should be addressed bilaterally’: India tells US, no need for unilateral 301 investigationThe Times of India India rejects US probe into ‘unfair practices’, ‘forced labour’ as trade talks resumeTelegraph India US 301 probe: India denies allegations, demands end of both probesThe Economic…

For Ben Sasse, Revolution Medicines’ pancreatic cancer trial felt like his best, only optionstatnews.com Revolution Medicines says its potential breakthrough pancreatic cancer drug passes late-stage trialcnbc Two new drugs offer hope for pancreatic cancertime magazine Revolution’s much-touted RAS inhibitor meets key survival milestones in Phase 3 pancreatic cancer trialfierce biotech New pancreatic cancer drug alraglusib…